Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF582 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | TMEFF1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
mRNA | SCGB2B2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | GABRB3 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
mRNA | YWHAG | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | CERK | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | NUMA1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | TMEM57 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | C19orf57 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | ZSCAN30 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |